MedTrace Logo

Post Covid-19 Vaccination Development or Flare of ARD

NCT05160428 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2023-01-11

No results posted yet for this study

Summary

Many patients develop autoimmune diseases after covid-19 vaccination, whether related to the vaccination or not, is still under study. This study will describe potential flare of ARD after COVID-19 vaccination, whether it leads to activity or new MSK manifestations development.

Conditions

  • COVID-19
  • Vaccination; Infection
  • Rheumatic Diseases

Interventions

BIOLOGICAL

COVID-19 vaccination

different types of covid-19 vaccinations.

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Mohamed Abuzaid, MD · Tanta University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-01
Primary Completion
2023-09-30
Completion
2023-10-31

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05160428 on ClinicalTrials.gov